Introducing the Launch of SMi’s Injectable Drug Delivery 2018
London, United Kingdom, January 18, 2018 --(PR.com)-- Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, they are thrilled to introduce the launch of Injectable Drug Delivery.
Conference Overview:
The Global Injectable Drug Delivery Market is expected to reach $789.7 billion USD by 2024, with a compound annual growth rate (CAGR) of 11.5% during the period of 2017 to 2024, according to Research Markets Reports. Therefore, the conference will aim to discuss the key developments in this field and the latest technological advancements.
Network and learn from leading professionals such as:
Chairs for 2018:
- Jean-René Authelin, Global Head, Pharmaceutical Engineering, Sanofi
- Joel Richard, Senior Vice President, Peptides Development, Ipsen
Key Speakers Include:
- Anand Subramony, Vice President, Novel Product Technologies, MedImmune
- Jean-René Authelin, Global Head, Pharmaceutical Engineering, Sanofi
- Joel Richard, Senior Vice President, Peptides Development, Ipsen
- René Holm, Head & Scientific Director, Liquids & Parenterals, Janssen
- Ahmed Youssef, Head of Parenteral Unit, Sanofi
- Maxime Gaillot, Senior Device Engineer, Roche
- Fie Falck Larsen, Senior Usability Engineer, Injection Devices, Global Research and Development, LEO Pharma
- Francesco Malavasi, Medical Device Quality Device Risk Manager, Novartis
Featured Highlights this May:
- Evaluate solutions for high-volume and highly-viscous drug formulations and explore their increasing market opportunities
- Revolutionise the patient experience through connected technologies, wearable injectors and maintenance of patient-centric design processes
- Gain insight into the future of the design strategies of industry-thought leaders
- Discover the latest manufacturing processes for tackling quality assurance issues
- Learn how vial-based novel delivery technologies can overcome complex dosing regimens
- Discover how nanosystems can help address present and future challenges in injectable peptide delivery
Plus...Two Interactive Half-Day Post-Conference Workshops.
For those looking to attend there are early-bird rates available online.
Further information is available at: www.injectable-drug-delivery.com/prc
SMi presents the Launch of:
Injectable Drug Delivery
Date: 16th – 17th May 2018
Workshops: 15th May 21018
Location: Holiday Inn Kensington Forum, London UK
Website: www.injectable-drug-delivery.com/prc
Contact Information:
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Conference Overview:
The Global Injectable Drug Delivery Market is expected to reach $789.7 billion USD by 2024, with a compound annual growth rate (CAGR) of 11.5% during the period of 2017 to 2024, according to Research Markets Reports. Therefore, the conference will aim to discuss the key developments in this field and the latest technological advancements.
Network and learn from leading professionals such as:
Chairs for 2018:
- Jean-René Authelin, Global Head, Pharmaceutical Engineering, Sanofi
- Joel Richard, Senior Vice President, Peptides Development, Ipsen
Key Speakers Include:
- Anand Subramony, Vice President, Novel Product Technologies, MedImmune
- Jean-René Authelin, Global Head, Pharmaceutical Engineering, Sanofi
- Joel Richard, Senior Vice President, Peptides Development, Ipsen
- René Holm, Head & Scientific Director, Liquids & Parenterals, Janssen
- Ahmed Youssef, Head of Parenteral Unit, Sanofi
- Maxime Gaillot, Senior Device Engineer, Roche
- Fie Falck Larsen, Senior Usability Engineer, Injection Devices, Global Research and Development, LEO Pharma
- Francesco Malavasi, Medical Device Quality Device Risk Manager, Novartis
Featured Highlights this May:
- Evaluate solutions for high-volume and highly-viscous drug formulations and explore their increasing market opportunities
- Revolutionise the patient experience through connected technologies, wearable injectors and maintenance of patient-centric design processes
- Gain insight into the future of the design strategies of industry-thought leaders
- Discover the latest manufacturing processes for tackling quality assurance issues
- Learn how vial-based novel delivery technologies can overcome complex dosing regimens
- Discover how nanosystems can help address present and future challenges in injectable peptide delivery
Plus...Two Interactive Half-Day Post-Conference Workshops.
For those looking to attend there are early-bird rates available online.
Further information is available at: www.injectable-drug-delivery.com/prc
SMi presents the Launch of:
Injectable Drug Delivery
Date: 16th – 17th May 2018
Workshops: 15th May 21018
Location: Holiday Inn Kensington Forum, London UK
Website: www.injectable-drug-delivery.com/prc
Contact Information:
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Pav Solanki
+44 (0) 207 827 6048
http://www.injectable-drug-delivery.com/prc
Contact
Pav Solanki
+44 (0) 207 827 6048
http://www.injectable-drug-delivery.com/prc
Categories